SEC Sues Imaging Diagnostic Systems and Top Execs Amid Failed FDA Bids and IRS Issues

Federal industry watchdogs accuse Imaging Diagnostic Systems and its lead executives of deliberately misleading investors after the company repeatedly missed FDA deadlines for its breast imaging system and failed to remit its payroll taxes.
DeviceSpace